Polmacoxib is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation.
Specification: Moligand™, ≥98%
Molecular Formula: C18H16FNO4S
Molecular Weight: 361.39
PubChem CID: 9841854
Isomeric SMILES: CC1(C(=O)C(=C(O1)C2=CC=C(C=C2)S(=O)(=O)N)C3=CC(=CC=C3)F)C
- UPC:
- 51373426
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P612891-10mg
- CAS:
- 301692-76-2
- Product Size:
- 10mg